SUBJECTS : Clinical | Mass Spectrometry | Pathology | Omics | Imaging | Laboratory Medicin
Journal of Mass Spectrometry and Advances in the Clinical Lab: 2023, vol: 28, issue:
- 1)- Christopher M Shuford, Evan W McConnell, Stacy Dee, Russell P Grant. Pre-analytical conditions influencing analysis of folate in dried plasma microsamples. Journal of mass spectrometry and advances in the clinical lab. 2023, 28: 1-8
Cited : 1Read More - 2)- Marlen Menlyadiev, Raymond T Suhandynata, Kyle Lund, Michael J Kelner, Robert L Fitzgerald. Evaluating the performance of the Roche FEN2 fentanyl immunoassay and its clinical implementation: The role of LDT-based mass spectrometry testing. Journal of mass spectrometry and advances in the clinical lab. 2023, 28: 105-113Cited : 6Read More
- 3)- Sedat Abusoglu, Duygu Eryavuz Onmaz, Gulsum Abusoglu, Fatma Humeyra Yerlikaya, Ali Unlu. Measurement of kynurenine pathway metabolites by tandem mass spectrometry. Journal of mass spectrometry and advances in the clinical lab. 2023, 28: 114-121Cited : 5Read More
- 4)- Nittaya Limsuwanachot, Budsaba Rerkamnuaychoke, Pimjai Niparuck, Roongrudee Singdong, Adcharee Kongruang, Piyapha Hirunpatrawong, Thanaporn Siriyakorn, Pa-Thai Yenchitsomanus, Teerapong Siriboonpiputtana. A customized mass array panel for :: tyrosine kinase domain mutation screening in chronic myeloid leukemia. Journal of mass spectrometry and advances in the clinical lab. 2023, 28: 122-132Cited : 2Read More
- 5)- Deborah French. Clinical utility of laboratory developed mass spectrometry assays for steroid hormone testing. Journal of mass spectrometry and advances in the clinical lab. 2023, 28: 13-19Cited : 8Read More
- 6)- David R Barnidge, Angela Dispenzieri, Dragan Jevremovic, David L Murray. Analysis of monoclonal immunoglobulins from bone marrow plasma cells using immunopurification and LC-MS. Journal of mass spectrometry and advances in the clinical lab. 2023, 28: 133-141Cited : 0Read More
- 7)- Yuan Lin, Archana M Agarwal, Lissa C Anderson, Alan G Marshall. Discovery of a biomarker for β-Thalassemia by HPLC-MS and improvement from Proton Transfer Reaction - Parallel Ion Parking. Journal of mass spectrometry and advances in the clinical lab. 2023, 28: 20-26Cited : 3Read More
- 8)- Gregory J Tsongalis. Molecular diagnostics and the laboratory developed test: A tale of success and the potential impacts of increased regulation. Journal of mass spectrometry and advances in the clinical lab. 2023, 28: 27-29Cited : 0Read More
- 9)- Yanchun Lin, Stefani N Thomas. Impact of VALID Act implementation on mass spectrometry-based clinical proteomic laboratory developed tests. Journal of mass spectrometry and advances in the clinical lab. 2023, 28: 30-34Cited : 3Read More
- 10)- A Sens, S Rischke, L Hahnefeld, E Dorochow, S M G Schäfer, D Thomas, M Köhm, G Geisslinger, F Behrens, R Gurke. Pre-analytical sample handling standardization for reliable measurement of metabolites and lipids in LC-MS-based clinical research. Journal of mass spectrometry and advances in the clinical lab. 2023, 28: 35-46Cited : 25Read More
- 11)- S Rischke, L Hahnefeld, B Burla, F Behrens, R Gurke, T J Garrett. Small molecule biomarker discovery: Proposed workflow for LC-MS-based clinical research projects. Journal of mass spectrometry and advances in the clinical lab. 2023, 28: 47-55Cited : 15Read More
- 12)- Alec Saitman. How the VALID Act could affect patient access to laboratory developed testing for therapeutic drug monitoring. Journal of mass spectrometry and advances in the clinical lab. 2023, 28: 56-59Cited : 1Read More
- 13)- Brian N Kelly. UTI detection by PCR: Improving patient outcomes. Journal of mass spectrometry and advances in the clinical lab. 2023, 28: 60-62Cited : 1Read More
- 14)- K Aaron Geno, Mark A Cervinski. Impact of the loss of Laboratory Developed Mass Spectrometry testing at a major academic medical center. Journal of mass spectrometry and advances in the clinical lab. 2023, 28: 63-66Cited : 4Read More
- 15)- Melissa M Budelier, Jacqueline A Hubbard. The regulatory landscape of laboratory developed tests: Past, present, and a perspective on the future. Journal of mass spectrometry and advances in the clinical lab. 2023, 28: 67-69Cited : 10Read More
- 16)- Jaime H Noguez, Christopher D Koch. Bridging the gap: The critical role of laboratory developed tests in clinical toxicology. Journal of mass spectrometry and advances in the clinical lab. 2023, 28: 70-74Cited : 4Read More
- 17)- Kara L Lynch. A case series evaluation of comprehensive drug testing in the pediatric acute care setting. Journal of mass spectrometry and advances in the clinical lab. 2023, 28: 75-79Cited : 1Read More
- 18)- Dustin R Bunch. Pediatric laboratory developed tests filling the gaps for children in crisis. Journal of mass spectrometry and advances in the clinical lab. 2023, 28: 80-81Cited : 1Read More
- 19)- Judith A Stone, J Grace van der Gugten. Quantitative tandem mass spectrometry in the clinical laboratory: Regulation and opportunity for validation of laboratory developed tests. Journal of mass spectrometry and advances in the clinical lab. 2023, 28: 82-90Cited : 2Read More
- 20)- Ashley R Rackow, Claire E Knezevic. A persistently febrile patient post-bone marrow transplant. Journal of mass spectrometry and advances in the clinical lab. 2023, 28: 9-12Cited : 1Read More
- 21)- Kyle Lund, Marlen Menlyadiev, Kyunghoon Lee, Michael J Kelner, Robert L Fitzgerald, Raymond T Suhandynata. Comparison of two highly sensitive benzodiazepine immunoassay lab developed tests for urine drug testing in clinical specimens. Journal of mass spectrometry and advances in the clinical lab. 2023, 28: 91-98Cited : 2Read More
- 22)- Priscilla S-W Yeung, Paige Miller, Tran Bao Lai-Nyugen, Phil Cheng, Amira Ibrahim, Run-Zhang Shi, Raffick A R Bowen, Ruben Yiqi Luo. Mass spectrometry quantitation of immunosuppressive drugs in clinical specimens using online solid-phase extraction and accurate-mass full scan-single ion monitoring. Journal of mass spectrometry and advances in the clinical lab. 2023, 28: 99-104Cited : 2Read More
